Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/70a37aec-1dfd-4b2e-8c8c-99467b4d32e7/

INDV

Indivior PLC Ordinary Shares
Chart
$37.62
Latest Week 2026-06-05
HealthcareDrug Manufacturers - Specialty & GenericMID
Snapshot 2026-06-07 · 0.0w · Fresh
0.33
OS Score
26.0%
Value
17.0%
Quality
96.0%
Momentum
4/9
F-Score
0.210
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
3 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
8.7%
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
12-1 181%
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
RAM 4.33
V
Value Analysis
Cheapness relative to fundamentals
26.0%ile
P/E
19.3×
P/S
3.8×
E/P
0.0517
FCF Yield
-0.004
EBITDA/EV
0.087
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
71.00000000
/100 — 1=cheapest
VC2 (Trending Value)
74.00000000
/100
VC3 (Buyback)
74.00000000
/100
Negative FCF yield (-0.4%) — the business is currently cash-consumptive.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
17.0%ile
ROE
-1.743
ROA
0.210
Net Margin
0.194
Op Margin
0.337
GPA
0.896
D/E
-9.31
Current
0.86
F-Score
4/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.102
Stability
1.876
lower=better
Accruals
0.296
lower=better
5yr Consist
No
Conservative balance sheet with D/E of -9.31. Accruals ratio of 0.296 is elevated — earnings quality may be lower than headline numbers suggest.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
96.0%ile
6M Return
7.1%
12M Return
167.3%
12-1 Mom
180.7%
Risk-Adj
4.33
Vol 252d
41.8%
Vol 60d
82.7%
↑ Expanding
Max DD 12M
-20.0%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 181% is very strong — a clear uptrend. Risk-adjusted momentum of 4.33 is excellent — strong returns relative to volatility. Near-term vol (83%) is expanding vs long-term (42%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.33
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 500 peers
Sector Value %ile
7.8%
Sector Quality %ile
5.4%
P/E z-score
-0.11
Sector Avg OS
63.3%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
IRWD Ironwood Pharmaceuticals Inc 99.0% 93.0% 86.0% 98.0%
FBIO Fortress Biotech Inc 98.0% 97.0% 93.0% 74.0%
RIGL Rigel Pharmaceuticals Inc 98.0% 94.0% 92.0% 76.0%
FBIOP Fortress Biotech Inc Pref Series A 97.0% 81.0% 95.0% 90.0%
PBYI Puma Biotechnology Inc 97.0% 80.0% 97.0% 92.0%
CGEN Compugen 97.0% 90.0% 95.0% 76.0%
WW WW International, Inc. Common Stock 97.0% 88.0% 80.0% 99.0%
MD Mednax Inc 96.0% 87.0% 80.0% 87.0%
Factor Interactions
Hot but Volatile
Strong momentum (96th) but high volatility (42%). Momentum could reverse sharply.
Volatility Expanding
60-day vol (83%) significantly exceeds 252-day (42%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
D
40.9% avg (6 factors)
Quality
B
62.0% avg (8 factors)
Momentum
A
86.6% avg (4 factors)
Risk
C
47.1% avg (1 factors)
High quality business commanding a premium price. The market recognises the quality — returns from here depend on continued fundamental execution.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.330—0—
Value %ile0.260—1—
Quality %ile0.170—1—
Momentum %ile0.960—1—
F-Score4.000—1—
Confidence0.909—1—
Volatility0.418—1—
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
19.33
Earnings Yield (E/P)
0.0517
Price / Sales
3.76
FCF Yield
-0.4%
EBITDA / EV
8.7%
Sales Yield (1/P·S)
0.2496
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
-174.3%
Return on Assets
21.0%
Net Margin
19.4%
Operating Margin
33.7%
Gross Profit / Assets
Novy-Marx GPA
89.6%
Debt / Equity
-9.31
Current Ratio
0.86
Accruals Ratio
(NI-OCF)/Assets — lower=better
0.296
MomentumPrice trend strength over different horizons
6M Return
7.1%
12M Return
167.3%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
180.7%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
4.33
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
10.2%
Earnings Stability (CV)
Lower = more stable
1.876
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
4
Dividend Yield
0.0%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
71
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
74
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
74
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity